Telemonitoring With a Connected Glucose Meter Improves Glycemia Among People With Insulin-Treated Type 2 Diabetes
Authors' conclusion
Telemonitoring and titration of insulin using a connected glucose meter resulted in significant improvements in glycemia, characterized by a reduction in HbA1c, increase in PIR, and reduction in glycemic variability without any increase in hypoglycemia.
Study context
- Population
- Adults with insulin-treated T2D (≥6 months diabetes, ≥3 months insulin), hemoglobin A1c (HbA1c) ≥8.5% and ≤12.5%, body mass index (BMI) ≤40 kg/m²; 55% women, mean age 57.9 years, mean BMI 27.8 kg/m², baseline HbA1c 9.8% (83.7 mmol/mol)
- Participants
- 40 adults
- Outcome
- HbA1c
- Follow-up
- Week 24
Methodological detailssingle-centre
- Single-centre
Main finding
As reported in the abstract
HbA1c change from baseline
Mean HbA1c improved
1.7%
Further findings
Glycemic variability (% CV), baseline to week 24
- % CV reduced from 32.9% to 30.7%
- P <.01
Blood glucose (BG) readings in range 70-180 mg/dL (PIR), baseline to week 24
- PIR increased from 58.8% to 67.1%
- P <.01
Total daily insulin dose · 24 weeks
- Median increase in total daily insulin dose
- 0.04 U/kg/d
Safety
BG readings below range <70 mg/dL (PBR) · week 24
- No change in PBR
Weight gain · 24 weeks
- Weight gain
- 0.9 kg
Original publication
Telemonitoring With a Connected Glucose Meter Improves Glycemia Among People With Insulin-Treated Type 2 Diabetes. J Diabetes Sci Technol. Published 24 February 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →